Andreas Tiede

40PUBLICATIONS
67CO-AUTHORS
Injury preventionEpidemiological methodsBiofabricationApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|Aug 13, 2026
Post Hoc Analyses of A-SURE and PREVENT Confirm the Effectiveness of rFVIIIFc Prophylaxis Across All Ages, BMIs, Severities, and Inhibitor Histories.

|Jun 15, 2026
Management of Breakthrough Bleeding During Emicizumab Prophylaxis in Acquired Haemophilia A: Data From the GTH-AHA-EMI Study.

|Feb 03, 2026
Pharmacodynamic Interaction Between Emicizumab and Coagulation Factor VIII.

Matthias Chill, Emma L Konarski, Annika Klingberg

|Aug 12, 2025
Sustained survival benefit of emicizumab and postponed immunosuppression in acquired hemophilia A.

Inga M Schimansky, Christiane Dobbelstein, Robert Klamroth

|Apr 02, 2024

Andreas Tiede, Sophie Susen, Ton Lisman

|Sep 27, 2023
von Willebrand factor modulates immune complexes and the recall response against factor VIII in a murine hemophilia A model.

Olga Oleshko, Nadine Vollack-Hesse, Andreas Tiede

Pageof 7

Frequent Collaborators

5 joint publications

Flora Peyvandi

4 joint publications

Robert Klamroth

4 joint publications

Giancarlo Castaman

4 joint publications

Christian Pfrepper